{"id":"https://openalex.org/W2411025399","doi":null,"title":"Effects of anticholinesterase drugs tacrine and E2020, the 5-HT(3) antagonist ondansetron, and the H(3) antagonist thioperamide, in models of cognition and cholinergic function.","display_name":"Effects of anticholinesterase drugs tacrine and E2020, the 5-HT(3) antagonist ondansetron, and the H(3) antagonist thioperamide, in models of cognition and cholinergic function.","publication_year":1996,"publication_date":"1996-11-01","ids":{"openalex":"https://openalex.org/W2411025399","mag":"2411025399","pmid":"https://pubmed.ncbi.nlm.nih.gov/11224448"},"language":"en","primary_location":{"id":"pmid:11224448","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11224448","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Behavioural pharmacology","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109095552","display_name":"D.L. Kirkby","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I141584323","display_name":"University of Hertfordshire","ror":"https://ror.org/0267vjk41","country_code":"GB","type":"education","lineage":["https://openalex.org/I141584323"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"D.L. Kirkby","raw_affiliation_strings":["Glaxo Unit for Behavioural Psychopharmacology, Division of Biosciences, University of Hertfordshire, Hatfield, Herts, AL 10 9AB; Neuroscience Unit, Glaxo Wellcome Research and Development Ltd, Stevenage, Herts, SG1 2NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Glaxo Unit for Behavioural Psychopharmacology, Division of Biosciences, University of Hertfordshire, Hatfield, Herts, AL 10 9AB; Neuroscience Unit, Glaxo Wellcome Research and Development Ltd, Stevenage, Herts, SG1 2NY","institution_ids":["https://openalex.org/I141584323"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111670959","display_name":"D.N.C. Jones","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D.N.C. Jones","raw_affiliation_strings":["Neuroscience Unit, Glaxo Wellcome Research and Development Ltd, Stevenage, Herts, SG1 2NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience Unit, Glaxo Wellcome Research and Development Ltd, Stevenage, Herts, SG1 2NY","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110575113","display_name":"Jen Barnes","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J.C. Barnes","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5027303286","display_name":"Guy A. Higgins","orcid":"https://orcid.org/0000-0002-0187-8697","observed_orcids":["https://orcid.org/0000-0002-0187-8697"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G.A. Higgins","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.8728,"has_fulltext":false,"cited_by_count":53,"citation_normalized_percentile":{"value":0.86829083,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"7","issue":"6","first_page":"513","last_page":"525"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tacrine","display_name":"tacrine","score":0.9940000176429749},{"id":"https://openalex.org/keywords/donepezil","display_name":"donepezil","score":0.9869999885559082},{"id":"https://openalex.org/keywords/ondansetron","display_name":"ondansetron","score":0.8640000224113464},{"id":"https://openalex.org/keywords/thioperamide","display_name":"thioperamide","score":1.0},{"id":"https://openalex.org/keywords/acetylcholinesterase-inhibitors","display_name":"acetylcholinesterase inhibitors","score":0.9769999980926514},{"id":"https://openalex.org/keywords/cholinergic-function","display_name":"cholinergic activity","score":0.8420000076293945},{"id":"https://openalex.org/keywords/cognitive-impairment","display_name":"cognitive impairment","score":0.5630000233650208},{"id":"https://openalex.org/keywords/scopolamine-induced-amnesia","display_name":"scopolamine-induced amnesia","score":0.7260000109672546},{"id":"https://openalex.org/keywords/short-term-memory","display_name":"short-term memory","score":0.9580000042915344},{"id":"https://openalex.org/keywords/attention","display_name":"attention","score":0.9829999804496765},{"id":"https://openalex.org/keywords/5-ht3-receptor-antagonists","display_name":"5-HT3 receptor antagonists","score":0.7350000143051147},{"id":"https://openalex.org/keywords/histamine-h3-receptor-antagonists","display_name":"histamine H3 receptor antagonists","score":0.843999981880188}],"concepts":[{"id":"https://openalex.org/C2779046751","wikidata":"https://www.wikidata.org/wiki/Q421076","display_name":"Tacrine","level":4,"score":0.9323976039886475},{"id":"https://openalex.org/C2778997900","wikidata":"https://www.wikidata.org/wiki/Q7784686","display_name":"Thioperamide","level":5,"score":0.8204413652420044},{"id":"https://openalex.org/C2777170512","wikidata":"https://www.wikidata.org/wiki/Q410011","display_name":"Ondansetron","level":3,"score":0.7224348187446594},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5594092011451721},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5488600730895996},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.5413053631782532},{"id":"https://openalex.org/C22885893","wikidata":"https://www.wikidata.org/wiki/Q4862743","display_name":"Cholinergic","level":2,"score":0.4875037372112274},{"id":"https://openalex.org/C2776723954","wikidata":"https://www.wikidata.org/wiki/Q3001265","display_name":"Muscarinic antagonist","level":4,"score":0.46855124831199646},{"id":"https://openalex.org/C2780904820","wikidata":"https://www.wikidata.org/wiki/Q415081","display_name":"Donepezil","level":4,"score":0.45939064025878906},{"id":"https://openalex.org/C2778122271","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Receptor antagonist","level":4,"score":0.42350298166275024},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3711509108543396},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.359001100063324},{"id":"https://openalex.org/C2778816929","wikidata":"https://www.wikidata.org/wiki/Q22676679","display_name":"Acetylcholinesterase","level":3,"score":0.3127484917640686},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.26404523849487305},{"id":"https://openalex.org/C63180777","wikidata":"https://www.wikidata.org/wiki/Q288395","display_name":"Histamine H3 receptor","level":4,"score":0.21802890300750732},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.20678094029426575},{"id":"https://openalex.org/C2780852908","wikidata":"https://www.wikidata.org/wiki/Q127076","display_name":"Vomiting","level":2,"score":0.1911950409412384},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.16335627436637878},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.1077655553817749},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.0},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"pmid:11224448","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11224448","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Behavioural pharmacology","raw_type":"Journal Article"},{"id":"mag:2411025399","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11224448","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2097375972","https://openalex.org/W1999560853","https://openalex.org/W1973449292","https://openalex.org/W2096813379","https://openalex.org/W2044436505","https://openalex.org/W1981093285","https://openalex.org/W2069170979","https://openalex.org/W1601487305","https://openalex.org/W2164145341","https://openalex.org/W2018537867"],"abstract_inverted_index":{"This":[0],"study":[1],"presents":[2],"a":[3,183,224],"comparison":[4],"between":[5],"two":[6],"inhibitors":[7],"of":[8,27,90,117,154,218],"acetylcholinesterase,":[9],"tacrine":[10,80,97,181,203],"and":[11,19,30,54,73,82,111,135,141,180,212,220],"E2020":[12,83,112,179,192,200],"(Donepezil),":[13],"the":[14,20,46,55,70,115,121,128,132,152,159,167,175,188],"5-HT(3)":[15],"receptor":[16,22],"antagonist":[17,23],"ondansetron,":[18],"H(3)":[21],"thioperamide,":[24],"in":[25,32,68,120,131,158,170,187,209,227],"models":[26,130,189,229],"cholinergic":[28],"function":[29],"cognition":[31],"male,":[33],"Lister":[34],"hooded":[35],"rats.":[36],"The":[37,216],"cognitive":[38,172],"tests":[39],"used":[40],"were":[41],"an":[42],"operant":[43],"VI20":[44,122,160],"task,":[45],"delayed":[47],"match":[48],"to":[49,76,145,205,222],"position":[50],"task":[51,60],"(short-term":[52],"memory)":[53],"5-choice":[56],"serial":[57],"reaction":[58],"time":[59],"(attention).":[61],"Scopolamine":[62],"(SCOP)":[63],"(0.075mg/kg":[64],"s.c.)":[65],"was":[66,193],"utilised":[67],"both":[69,125,178],"short-term":[71,133],"memory":[72,134],"attention":[74,136],"tasks":[75,137],"impair":[77],"performance.":[78],"Both":[79],"(1-30mg/kg)":[81],"(1-10mg/kg)":[84],"similarly":[85],"produced":[86,98],"overt":[87,147],"cholinomimetic":[88,102,148,214],"signs":[89,103,149],"likely":[91],"central":[92,211],"origin":[93],"(hypothermia,":[94],"tremor),":[95],"although":[96,191],"more":[99,197],"profound":[100],"peripheral":[101,213],"(miosis,":[104],"secretory":[105],"signs)":[106],"than":[107],"E2020.":[108],"Tacrine":[109],"(30mg/kg)":[110],"(10mg/kg)":[113],"reduced":[114],"number":[116,153],"reinforcements":[118,156],"gained":[119,157],"schedule.":[123,161],"Similarly,":[124],"drugs":[126],"attenuated":[127,166],"SCOP-impairment":[129],"(1-3mg/kg).":[138],"Ondansetron":[139],"(10ng/kg-1mg/kg)":[140],"thioperamide":[142,165,221],"(0.2-10mg/kg)":[143],"failed":[144],"elicit":[146],"or":[150],"influence":[151],"food":[155],"Neither":[162],"ondansetron":[163,219],"nor":[164],"SCOP-induced":[168,225],"impairment":[169],"either":[171],"task.":[173],"From":[174],"present":[176],"studies,":[177],"showed":[182],"similar":[184],"behavioural":[185],"profile":[186],"used,":[190],"about":[194],"three":[195],"times":[196],"potent.":[198],"Furthermore,":[199],"but":[201],"not":[202],"appeared":[204],"show":[206],"some":[207],"discrimination":[208],"eliciting":[210],"signs.":[215],"failure":[217],"reverse":[223],"deficit":[226],"these":[228],"is":[230],"discussed.":[231]},"counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}